HCA Healthcare IncFind Ratings Reports
HCA HEALTHCARE INC's gross profit margin for the second quarter of its fiscal year 2021 has significantly increased when compared to the same period a year ago. The company has grown sales and net income significantly, outpacing the average growth rates of competitors within its subsector. HCA HEALTHCARE INC has average liquidity. Currently, the Quick Ratio is 1.03 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year.
At the same time, stockholders' equity ("net worth") has greatly increased by 66.79% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q2 FY21||Q2 FY20|
|Net Sales ($mil)||14435.0||11068.0|
|Net Income ($mil)||1450.0||1079.0|
|Balance Sheet||Q2 FY21||Q2 FY20|
|Cash & Equiv. ($mil)||1235.0||4743.0|
|Total Assets ($mil)||48164.0||48709.0|
|Total Debt ($mil)||34339.0||32473.0|
|Profitability||Q2 FY21||Q2 FY20|
|Gross Profit Margin||23.03||17.34|
|Return on Assets||10.31||6.86|
|Return on Equity||0.0||0.0|
|Debt||Q2 FY21||Q2 FY20|
|Share Data||Q2 FY21||Q2 FY20|
|Shares outstanding (mil)||322.83||337.96|
|Div / share||0.48||0.0|
|Book value / share||-1.84||-5.28|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||1367185.0||1384657.0|
HOLD. This stock's P/E ratio indicates a discount compared to an average of 17.50 for the Hospitals subsector and a significant discount compared to the S&P 500 average of 33.99. Normally, for additional comaprison, we would look at the price-to-book ratio; however, this company's price-to-book ratio is negative making the value useless for comparisons. The current price-to-sales ratio is well below the S&P 500 average and is also below the subsector average, indicating a discount. After reviewing these and other key valuation criteria, HCA HEALTHCARE INC proves to trade at a discount to investment alternatives.
|HCA 17.49||Peers 54.14||HCA 24.40||Peers 20.71|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
HCA is trading at a significant discount to its peers.
Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
HCA is trading at a premium to its peers.
|HCA 14.41||Peers 17.07||HCA 0.33||Peers 1.13|
Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.
HCA is trading at a discount to its peers.
Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
HCA trades at a significant discount to its peers.
|HCA NM||Peers 19.83||HCA 50.30||Peers 29.01|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
HCA's P/B is negative making this valuation measure meaningless.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
HCA is expected to have an earnings growth rate that significantly exceeds its peers.
|HCA 1.47||Peers 1.84||HCA 11.70||Peers 18.17|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
HCA is trading at a discount to its subsector on this measurement.
Lower. A sales growth rate that trails the subsector implies that a company is losing market share.
HCA significantly trails its peers on the basis of sales growth.